The advent of automated insulin delivery (AID) systems in 2020 marked a disruptive event in managing type 1 diabetes, benefiting children and adults alike. By 2024, advances in real-world data and research motivated an update to the French consensus on AID systems to expand accessibility, refine guidelines, and optimize patient follow-up. AID systems have consistently improved glycemic control by reducing HbA1c, increasing time-in-range (TIR), and minimizing hypoglycemia, with significant benefits even for specific populations such as individuals with poor glycemic control, brittle diabetes, children, very young children, pregnant women, those with insulin resistance or gastroparesis, or after bariatric surgery.
View Article and Find Full Text PDFThis review examines India's legal framework governing natural product sales, focusing on challenges and solutions. It analyses key legislation, including the Drugs and Cosmetics Act, Food Safety and Standards Act, and Biological Diversity Act, while addressing jurisdictional overlaps among bodies like FSSAI and CDSCO. Case studies highlight intellectual property disputes, quality control, mislabelling, false advertising, and unauthorised sales, emphasising consumer safety and public health.
View Article and Find Full Text PDFContext: Baseball is a popular sport in the United States, with widespread play among secondary school student-athletes. Baseball-related injuries may vary based on community-level socioeconomic status of schools. Objective: To describe the injuries sustained by secondary school baseball players from schools categorized by community-level socioeconomic status.
View Article and Find Full Text PDFToday's pharmaceutical products are seeing a massive increase in impurity profiling. A drug substance or product will inevitably contain contaminants in trace amounts. According to pharmaceutical chemistry, impurities are undesirable substances found in pharmaceutical compounds with therapeutic activity.
View Article and Find Full Text PDF